Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Enfusion, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 10,353 shares
@ $0
Granted 6,335 shares
@ $0 |
|
| 08/15/2023 |
4
| Bastone Bronwen (Chief People Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 117 shares
@ $0
Sold 41 shares
@ $7.89, valued at
$323.5 |
|
| 08/15/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 4,045 shares
@ $0
Sold 1,760 shares
@ $7.89, valued at
$13.9k
|
|
| 08/15/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 1,332 shares
@ $0 |
|
| 08/14/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 1,466 shares
@ $0 |
|
| 08/14/2023 |
4
| Bastone Bronwen (Chief People Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 130 shares
@ $0
Sold 44 shares
@ $8.1, valued at
$356.4 |
|
| 08/14/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 4,451 shares
@ $0
Sold 1,850 shares
@ $8.1, valued at
$15k
|
|
| 08/11/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 1,599 shares
@ $0 |
|
| 08/11/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 4,855 shares
@ $0
Sold 2,106 shares
@ $8.08, valued at
$17k
|
|
| 08/11/2023 |
4
| Bastone Bronwen (Chief People Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 141 shares
@ $0
Sold 50 shares
@ $8.08, valued at
$404 |
|
| 08/10/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 5,259 shares
@ $0
Sold 2,317 shares
@ $8.32, valued at
$19.3k
|
|
| 08/10/2023 |
4
| Bastone Bronwen (Chief People Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 153 shares
@ $0
Sold 55 shares
@ $8.32, valued at
$457.6 |
|
| 08/10/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 1,733 shares
@ $0 |
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/13/2023 |
4
| Hammoud Tarek (10% Owner) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Sold 1,000,000 shares
@ $10.7, valued at
$10.7M
|
|
| 06/28/2023 |
4
| Somers Deirdre (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 15,233 shares
@ $0 |
|
| 06/28/2023 |
4
| Spellacy Michael (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 15,233 shares
@ $0 |
|
| 06/28/2023 |
4
| Hauser Jan (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 15,233 shares
@ $0 |
|
| 06/28/2023 |
4
| DeRose Kathleen (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 15,233 shares
@ $0 |
|
| 06/28/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 15,233 shares
@ $0 |
|
| 06/16/2023 |
4
| Bernstein Bradford E (10% Owner) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 1,142,857 shares
@ $8.1195, valued at
$9.3M
|
|
| 05/26/2023 |
4
| Bastone Bronwen (Chief People Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 3,298 shares
@ $0
Paid exercise price by delivering 1,112 shares
@ $7.93, valued at
$8.8k
|
|
| 05/26/2023 |
4
| LEIBOWITZ LAWRENCE E (Director) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 37,396 shares
@ $0 |
|
| 05/26/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Granted 113,538 shares
@ $0
Paid exercise price by delivering 47,630 shares
@ $7.93, valued at
$377.7k
|
|
| 05/24/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Sold 3,877 shares
@ $8, valued at
$31k
Sold 50,000 shares
@ $7.91, valued at
$395.5k
|
|
| 05/12/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Sold 15,048 shares
@ $8.34, valued at
$125.5k
|
|
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/21/2023 |
4
| Groman Dan (Chief Technology Officer) has filed a Form 4 on Enfusion, Inc.|
Txns:
| Sold 3,877 shares
@ $10.94, valued at
$42.4k
|
|
|
|
|